Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and Geldanamycin

This article is cited by 806 publications.

1. Soosung Kang, Byoung Heon Kang. Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1. Journal of Medicinal Chemistry 2022, 65 (24) , 16155-16172. https://doi.org/10.1021/acs.jmedchem.2c01633
2. Polina Prokofeva, Stefanie Höfer, Maximilian Hornisch, Miriam Abele, Bernhard Kuster, Guillaume Médard. Merits of Diazirine Photo-Immobilization for Target Profiling of Natural Products and Cofactors. ACS Chemical Biology 2022, 17 (11) , 3100-3109. https://doi.org/10.1021/acschembio.2c00500
3. Maximilian Meixner, Martin Zachmann, Sebastian Metzler, Jonathan Scheerer, Martin Zacharias, Iris Antes. Dynamic Docking of Macrocycles in Bound and Unbound Protein Structures with DynaDock. Journal of Chemical Information and Modeling 2022, 62 (14) , 3426-3441. https://doi.org/10.1021/acs.jcim.2c00436
4. Jacob P. Walsh, Christopher P. Garnham, Ken K.-C. Yeung, Mark W. Sumarah. Ilyonectria Root Rot of Ginseng Is Attenuated via Enzymatic Degradation of the Extracellular Fe3+-Bound Siderophore N,N′,N″-Triacetylfusarinine C. ACS Agricultural Science & Technology 2022, 2 (2) , 402-408. https://doi.org/10.1021/acsagscitech.2c00023
5. Qi Xiong, Lu Xiao, Xiu-Qin Dong, Chun-Jiang Wang. Asymmetric Synthesis of Chiral Aza-macrodiolides via Iridium-Catalyzed Cascade Allylation/Macrolactonization. Organic Letters 2022, 24 (13) , 2579-2584. https://doi.org/10.1021/acs.orglett.2c00942
6. Helisa H. Wippel, Juan D. Chavez, Andrew D. Keller, James E. Bruce. Multiplexed Isobaric Quantitative Cross-Linking Reveals Drug-Induced Interactome Changes in Breast Cancer Cells. Analytical Chemistry 2022, 94 (6) , 2713-2722. https://doi.org/10.1021/acs.analchem.1c02208
7. Zhiran Ju, Wei Zhou, Hattan A. Alharbi, Daniel C. Howell, Taifo Mahmud. Modulation of Specialized Metabolite Production in Genetically Engineered Streptomyces pactum. ACS Chemical Biology 2021, 16 (11) , 2641-2650. https://doi.org/10.1021/acschembio.1c00718
8. Tatyana Almeida Tavella, Noeli Soares Melo da Silva, Natalie Spillman, Ana Carolina Andrade Vitor Kayano, Gustavo Capatti Cassiano, Adrielle Ayumi Vasconcelos, Antônio Pedro Camargo, Djane Clarys Baia da Silva, Diana Fontinha, Luis Carlos Salazar Alvarez, Letícia Tiburcio Ferreira, Kaira Cristina Peralis Tomaz, Bruno Junior Neves, Ludimila Dias Almeida, Daniel Youssef Bargieri, Marcus Vinicius Guimarães de Lacerda, Pedro Vitor Lemos Cravo, Per Sunnerhagen, Miguel Prudêncio, Carolina Horta Andrade, Stefanie Costa Pinto Lopes, Marcelo Falsarella Carazzolle, Leann Tilley, Elizabeth Bilsland, Júlio César Borges, Fabio Trindade Maranhão Costa. Violacein-Induced Chaperone System Collapse Underlies Multistage Antiplasmodial Activity. ACS Infectious Diseases 2021, 7 (4) , 759-776. https://doi.org/10.1021/acsinfecdis.0c00454
9. Jiawen Lyu, Chengfei Ruan, Xiaolei Zhang, Yan Wang, Kejia Li, Mingliang Ye. Microparticle-Assisted Precipitation Screening Method for Robust Drug Target Identification. Analytical Chemistry 2020, 92 (20) , 13912-13921. https://doi.org/10.1021/acs.analchem.0c02756
10. Juan D. Chavez, Andrew Keller, Jared P. Mohr, James E. Bruce. Isobaric Quantitative Protein Interaction Reporter Technology for Comparative Interactome Studies. Analytical Chemistry 2020, 92 (20) , 14094-14102. https://doi.org/10.1021/acs.analchem.0c03128
11. N. Arjunreddy Mallampudi, Beduru Srinivas, Jithender G. Reddy, Debendra K. Mohapatra. Total Synthesis and Structural Revision of Monocillin VII. Organic Letters 2019, 21 (15) , 5952-5956. https://doi.org/10.1021/acs.orglett.9b02075
12. Yingrong Xu, M. Ariel Geer Wallace, Michael C. Fitzgerald. Thermodynamic Analysis of the Geldanamycin–Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach. Journal of the American Society for Mass Spectrometry 2016, 27 (10) , 1670-1676. https://doi.org/10.1007/s13361-016-1457-2
13. Tai Wang, Pascal Mäser, and Didier Picard . Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles. Journal of Medicinal Chemistry 2016, 59 (13) , 6344-6352. https://doi.org/10.1021/acs.jmedchem.6b00591
14. Eléonore Lepvrier, Laura Moullintraffort, Michaël Nigen, Renan Goude, Diane Allegro, Pascale Barbier, Vincent Peyrot, Daniel Thomas, Alexis Nazabal, and Cyrille Garnier . Hsp90 Oligomers Interacting with the Aha1 Cochaperone: An Outlook for the Hsp90 Chaperone Machineries. Analytical Chemistry 2015, 87 (14) , 7043-7051. https://doi.org/10.1021/acs.analchem.5b00051
15. Brian E. Nordin, Yongsheng Liu, Arwin Aban, Heidi E. Brown, Jiangyue Wu, Anna K. Hainley, Jonathan S. Rosenblum, Tyzoon K. Nomanbhoy, and John W. Kozarich . ATP Acyl Phosphate Reactivity Reveals Native Conformations of Hsp90 Paralogs and Inhibitor Target Engagement. Biochemistry 2015, 54 (19) , 3024-3036. https://doi.org/10.1021/acs.biochem.5b00148
16. Changwook Lee, Hye-Kyung Park, Hanbin Jeong, Jaehwa Lim, An-Jung Lee, Keun Young Cheon, Chul-Su Kim, Ajesh P. Thomas, Boram Bae, Nam Doo Kim, Seong Heon Kim, Pann-Ghill Suh, Ja-Hyoung Ryu, and Byoung Heon Kang . Development of a Mitochondria-Targeted Hsp90 Inhibitor Based on the Crystal Structures of Human TRAP1. Journal of the American Chemical Society 2015, 137 (13) , 4358-4367. https://doi.org/10.1021/ja511893n
17. Andrew Anighoro, Dagmar Stumpfe, Kathrin Heikamp, Kristin Beebe, Leonard M. Neckers, Jürgen Bajorath, and Giulio Rastelli . Computational Polypharmacology Analysis of the Heat Shock Protein 90 Interactome. Journal of Chemical Information and Modeling 2015, 55 (3) , 676-686. https://doi.org/10.1021/ci5006959
18. Rohit Bhat, Sreedhar R. Tummalapalli, and David P. Rotella . Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors. Journal of Medicinal Chemistry 2014, 57 (21) , 8718-8728. https://doi.org/10.1021/jm500823a
19. Masayuki Isa, Daisuke Asanuma, Shigeyuki Namiki, Kazuo Kumagai, Hirotatsu Kojima, Takayoshi Okabe, Tetsuo Nagano, and Kenzo Hirose . High-Throughput Screening System To Identify Small Molecules That Induce Internalization and Degradation of HER2. ACS Chemical Biology 2014, 9 (10) , 2237-2241. https://doi.org/10.1021/cb500654q
20. Madhu Aeluri, Srinivas Chamakuri, Bhanudas Dasari, Shiva Krishna Reddy Guduru, Ravikumar Jimmidi, Srinivas Jogula, and Prabhat Arya . Small Molecule Modulators of Protein–Protein Interactions: Selected Case Studies. Chemical Reviews 2014, 114 (9) , 4640-4694. https://doi.org/10.1021/cr4004049
21. Eric J. Mejia, Steven T. Loveridge, George Stepan, Angela Tsai, Gregg S. Jones, Tiffany Barnes, Kimberly N. White, Marija Drašković, Karen Tenney, Manuel Tsiang, Romas Geleziunas, Tomas Cihlar, Nikos Pagratis, Yang Tian, Helen Yu, and Phillip Crews . Study of Marine Natural Products Including Resorcyclic Acid Lactones from Humicola fuscoatra That Reactivate Latent HIV-1 Expression in an in Vitro Model of Central Memory CD4+ T Cells. Journal of Natural Products 2014, 77 (3) , 618-624. https://doi.org/10.1021/np400889x
22. Russell R. A. Kitson and Christopher J. Moody . Learning from Nature: Advances in Geldanamycin- and Radicicol-Based Inhibitors of Hsp90. The Journal of Organic Chemistry 2013, 78 (11) , 5117-5141. https://doi.org/10.1021/jo4002849
23. Dong-Jo Chang, Hongchan An, Kyoung-suk Kim, Hyun Ho Kim, Jinkyung Jung, Jung Min Lee, Nam-Jung Kim, Young Taek Han, Hwayoung Yun, Sujin Lee, Geumwoo Lee, Seungbeom Lee, Ju Sung Lee, Jong-Ho Cha, Ji-Hyeon Park, Ji Won Park, Su-Chan Lee, Sang Geon Kim, Jeong Hun Kim, Ho-Young Lee, Kyu-Won Kim, and Young-Ger Suh . Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis. Journal of Medicinal Chemistry 2012, 55 (24) , 10863-10884. https://doi.org/10.1021/jm301488q
24. Christopher E. Taylor, Quintin Pan, and Anna K. Mapp . Synergistic Enhancement of the Potency and Selectivity of Small Molecule Transcriptional Inhibitors. ACS Medicinal Chemistry Letters 2012, 3 (1) , 30-34. https://doi.org/10.1021/ml200186r
25. James E. H. Day, Swee Y. Sharp, Martin G. Rowlands, Wynne Aherne, Angela Hayes, Florence I. Raynaud, William Lewis, S. Mark Roe, Chrisostomos Prodromou, Laurence H. Pearl, Paul Workman, and Christopher J. Moody . Targeting the Hsp90 Molecular Chaperone with Novel Macrolactams. Synthesis, Structural, Binding, and Cellular Studies. ACS Chemical Biology 2011, 6 (12) , 1339-1347. https://doi.org/10.1021/cb200196e
26. Genaro Pimienta, Kristina M. Herbert, and Lynne Regan . A Compound That Inhibits the HOP–Hsp90 Complex Formation and Has Unique Killing Effects in Breast Cancer Cell Lines. Molecular Pharmaceutics 2011, 8 (6) , 2252-2261. https://doi.org/10.1021/mp200346y
27. Xiao Yan Huang, Zhi Jie Shan, Hong Lin Zhai, Li Na Li, and Xiao Yun Zhang . Molecular Design of Anticancer Drug Leads Based on Three-Dimensional Quantitative Structure–Activity Relationship. Journal of Chemical Information and Modeling 2011, 51 (8) , 1999-2006. https://doi.org/10.1021/ci2002236
28. Robert L. Matts, Anshuman Dixit, Laura B. Peterson, Liang Sun, Sudhakar Voruganti, Palgunan Kalyanaraman, Steve D. Hartson, Gennady M. Verkhivker, and Brian S. J. Blagg . Elucidation of the Hsp90 C-Terminal Inhibitor Binding Site. ACS Chemical Biology 2011, 6 (8) , 800-807. https://doi.org/10.1021/cb200052x
29. Young-Wook Won, Sun-Mi Yoon, Chung Hee Sonn, Kyung-Mi Lee, and Yong-Hee Kim . Nano Self-Assembly of Recombinant Human Gelatin Conjugated with α-Tocopheryl Succinate for Hsp90 Inhibitor, 17-AAG, Delivery. ACS Nano 2011, 5 (5) , 3839-3848. https://doi.org/10.1021/nn200173u
30. Veronika Škedelj, Tihomir Tomašić, Lucija Peterlin Mašič, and Anamarija Zega . ATP-Binding Site of Bacterial Enzymes as a Target for Antibacterial Drug Design. Journal of Medicinal Chemistry 2011, 54 (4) , 915-929. https://doi.org/10.1021/jm101121s
31. Christopher W. Murray, Maria G. Carr, Owen Callaghan, Gianni Chessari, Miles Congreve, Suzanna Cowan, Joseph E. Coyle, Robert Downham, Eva Figueroa, Martyn Frederickson, Brent Graham, Rachel McMenamin, M. Alistair O’Brien, Sahil Patel, Theresa R. Phillips, Glyn Williams, Andrew J. Woodhead and Alison J.-A. Woolford. Fragment-Based Drug Discovery Applied to Hsp90. Discovery of Two Lead Series with High Ligand Efficiency. Journal of Medicinal Chemistry 2010, 53 (16) , 5942-5955. https://doi.org/10.1021/jm100059d
32. Iwona E. Wrona, Alexander Gozman, Tony Taldone, Gabriela Chiosis and James S. Panek . Synthesis of Reblastatin, Autolytimycin, and Non-Benzoquinone Analogues: Potent Inhibitors of Heat Shock Protein 90. The Journal of Organic Chemistry 2010, 75 (9) , 2820-2835. https://doi.org/10.1021/jo1000109
33. Marco A. Biamonte, Ryan Van de Water, Joseph W. Arndt, Robert H. Scannevin, Daniel Perret and Wen-Cherng Lee . Heat Shock Protein 90: Inhibitors in Clinical Trials. Journal of Medicinal Chemistry 2010, 53 (1) , 3-17. https://doi.org/10.1021/jm9004708
34. Pei-Pei Kung, Buwen Huang, Gang Zhang, Joe Zhongxiang Zhou, Jeff Wang, Jennifer A. Digits, Judith Skaptason, Shinji Yamazaki, David Neul, Michael Zientek, Jeff Elleraas, Pramod Mehta, Min-Jean Yin, Michael J. Hickey, Ketan S. Gajiwala, Caroline Rodgers, Jay F. Davies, II and Michael R. Gehring. Dihydroxyphenylisoindoline Amides as Orally Bioavailable Inhibitors of the Heat Shock Protein 90 (Hsp90) Molecular Chaperone. Journal of Medicinal Chemistry 2010, 53 (1) , 499-503. https://doi.org/10.1021/jm901209q
35. Stefan Bräse, Arantxa Encinas, Julia Keck and Carl F. Nising. Chemistry and Biology of Mycotoxins and Related Fungal Metabolites. Chemical Reviews 2009, 109 (9) , 3903-3990. https://doi.org/10.1021/cr050001f
36. Paul A. Brough, Xavier Barril, Jenifer Borgognoni, Patrick Chene, Nicholas G. M. Davies, Ben Davis, Martin J. Drysdale, Brian Dymock, Suzanne A. Eccles, Carlos Garcia-Echeverria, Christophe Fromont, Angela Hayes, Roderick E. Hubbard, Allan M. Jordan, Michael Rugaard Jensen, Andrew Massey, Angela Merrett, Antony Padfield, Rachel Parsons, Thomas Radimerski, Florence I. Raynaud, Alan Robertson, Stephen D. Roughley, Joseph Schoepfer, Heather Simmonite, Swee Y. Sharp, Allan Surgenor, Melanie Valenti, Steven Walls, Paul Webb, Mike Wood, Paul Workman and Lisa Wright . Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-d]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone. Journal of Medicinal Chemistry 2009, 52 (15) , 4794-4809. https://doi.org/10.1021/jm900357y
37. Yanyan Li, Tao Zhang, Yiqun Jiang, Hsiu-Fang Lee, Steven J. Schwartz and Duxin Sun . (−)-Epigallocatechin-3-gallate Inhibits Hsp90 Function by Impairing Hsp90 Association with Cochaperones in Pancreatic Cancer Cell Line Mia Paca-2. Molecular Pharmaceutics 2009, 6 (4) , 1152-1159. https://doi.org/10.1021/mp900037p
38. M. Kyle Hadden and Brian S. J. Blagg. Synthesis and Evaluation of Radamide Analogues, A Chimera of Radicicol and Geldanamycin. The Journal of Organic Chemistry 2009, 74 (13) , 4697-4704. https://doi.org/10.1021/jo900278g
39. Adam S. Duerfeldt, Gary E. L. Brandt and Brian S. J. Blagg. Design, Synthesis, and Biological Evaluation of Conformationally Constrained cis-Amide Hsp90 Inhibitors. Organic Letters 2009, 11 (11) , 2353-2356. https://doi.org/10.1021/ol900783m
40. Zong-Qiang Tian, Zhan Wang, Karen S. MacMillan, Yiqing Zhou, Christopher W. Carreras, Thomas Mueller, David C. Myles and Yaoquan Liu. Potent Cytotoxic C-11 Modified Geldanamycin Analogues. Journal of Medicinal Chemistry 2009, 52 (10) , 3265-3273. https://doi.org/10.1021/jm900098v
41. Jyoti P. Nandy, Michael Prakesch, Shahriar Khadem, P. Thirupathi Reddy, Utpal Sharma and Prabhat Arya . Advances in Solution- and Solid-Phase Synthesis toward the Generation of Natural Product-like Libraries. Chemical Reviews 2009, 109 (5) , 1999-2060. https://doi.org/10.1021/cr800188v
42. Chrisostomos Prodromou, James M. Nuttall, Stefan H. Millson, S. Mark Roe, Tiow-Suan Sim, Doreen Tan, Paul Workman, Laurence H. Pearl and Peter W. Piper . Structural Basis of the Radicicol Resistance Displayed by a Fungal Hsp90. ACS Chemical Biology 2009, 4 (4) , 289-297. https://doi.org/10.1021/cb9000316
43. Alison C. Donnelly, Jared R. Mays, Joseph A. Burlison, John T. Nelson, George Vielhauer, Jeffrey Holzbeierlein and Brian S. J. Blagg. The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity. The Journal of Organic Chemistry 2008, 73 (22) , 8901-8920. https://doi.org/10.1021/jo801312r
44. Christa C. Chrovian,, Beth Knapp-Reed, and, John Montgomery. Total Synthesis of Aigialomycin D:  Surprising Chemoselectivity Dependence on Alkyne Structure in Nickel-Catalyzed Cyclizations. Organic Letters 2008, 10 (5) , 811-814. https://doi.org/10.1021/ol702961v
45. Paul A. Brough, Wynne Aherne, Xavier Barril, Jenifer Borgognoni, Kathy Boxall, Julie E. Cansfield, Kwai-Ming J. Cheung, Ian Collins, Nicholas G. M. Davies, Martin J. Drysdale, Brian Dymock, Suzanne A. Eccles, Harry Finch, Alexandra Fink, Angela Hayes, Robert Howes, Roderick E. Hubbard, Karen James, Allan M. Jordan, Andrea Lockie, Vanessa Martins, Andrew Massey, Thomas P. Matthews, Edward McDonald, Christopher J. Northfield, Laurence H. Pearl, Chrisostomos Prodromou, Stuart Ray, Florence I. Raynaud, Stephen D. Roughley, Swee Y. Sharp, Allan Surgenor, D. Lee Walmsley, Paul Webb, Mike Wood, Paul Workman and Lisa Wright. 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer. Journal of Medicinal Chemistry 2008, 51 (2) , 196-218. https://doi.org/10.1021/jm701018h
46. Stefano Forli and, Maurizio Botta. Lennard-Jones Potential and Dummy Atom Settings to Overcome the AUTODOCK Limitation in Treating Flexible Ring Systems. Journal of Chemical Information and Modeling 2007, 47 (4) , 1481-1492. https://doi.org/10.1021/ci700036j
47. Rebecca M. Wilson and, Samuel J. Danishefsky. Pattern Recognition in Retrosynthetic Analysis:  Snapshots in Total Synthesis. The Journal of Organic Chemistry 2007, 72 (12) , 4293-4305. https://doi.org/10.1021/jo070871s
48. Yung-Tzung Huang and, Brian S. J. Blagg. A Library of Noviosylated Coumarin Analogues. The Journal of Organic Chemistry 2007, 72 (10) , 3609-3613. https://doi.org/10.1021/jo062083t
49. Rebecca M. Wilson and, Samuel J. Danishefsky. Small Molecule Natural Products in the Discovery of Therapeutic Agents:  The Synthesis Connection. The Journal of Organic Chemistry 2006, 71 (22) , 8329-8351. https://doi.org/10.1021/jo0610053
50. Joseph A. Burlison and, Brian S. J. Blagg. Synthesis and Evaluation of Coumermycin A1 Analogues that Inhibit the Hsp90 Protein Folding Machinery. Organic Letters 2006, 8 (21) , 4855-4858. https://doi.org/10.1021/ol061918j
51. Gabriela Chiosis and Len Neckers . Tumor Selectivity of Hsp90 Inhibitors: The Explanation Remains Elusive. ACS Chemical Biology 2006, 1 (5) , 279-284. https://doi.org/10.1021/cb600224w
52. Emilie Moulin,, Sofia Barluenga, and, Nicolas Winssinger. Concise Synthesis of Pochonin A, an HSP90 Inhibitor. Organic Letters 2005, 7 (25) , 5637-5639. https://doi.org/10.1021/ol052263+
53. Xiao Ming Yu,, Gang Shen,, Len Neckers,, Helen Blake,, Jeff Holzbeierlein,, Benjamin Cronk, and, Brian S. J. Blagg. Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues. Journal of the American Chemical Society 2005, 127 (37) , 12778-12779. https://doi.org/10.1021/ja0535864
54. Gang Shen and, Brian S. J. Blagg. Radester, a Novel Inhibitor of the Hsp90 Protein Folding Machinery. Organic Letters 2005, 7 (11) , 2157-2160. https://doi.org/10.1021/ol050580a
55. Jorge García-Fortanet,, John R. Debergh, and, Jef K. De Brabander. A Photochemical Entry to Depsides:  Synthesis of Gustastatin. Organic Letters 2005, 7 (4) , 685-688. https://doi.org/10.1021/ol047507p
56. Randell C. Clevenger and, Brian S. J. Blagg. Design, Synthesis, and Evaluation of a Radicicol and Geldanamycin Chimera, Radamide. Organic Letters 2004, 6 (24) , 4459-4462. https://doi.org/10.1021/ol048266o
57. Larry Yet. Chemistry and Biology of Salicylihalamide A and Related Compounds. Chemical Reviews 2003, 103 (11) , 4283-4306. https://doi.org/10.1021/cr030035s
58. Merritt B. Andrus,, Erik L. Meredith,, Erik J. Hicken,, Bryon L. Simmons,, Russell R. Glancey, and, Wei Ma. Total Synthesis of (+)-Geldanamycin and (−)-o-Quinogeldanamycin:  Asymmetric Glycolate Aldol Reactions and Biological Evaluation. The Journal of Organic Chemistry 2003, 68 (21) , 8162-8169. https://doi.org/10.1021/jo034870l
59. Merritt B. Andrus,, Erik J. Hicken,, Erik L. Meredith,, Bryon L. Simmons, and, John F. Cannon. Selective Synthesis of the para-Quinone Region of Geldanamycin. Organic Letters 2003, 5 (21) , 3859-3862. https://doi.org/10.1021/ol035400g
60. Zhi-Qiang Yang and, Samuel J. Danishefsky. A Concise Route to Benzofused Macrolactones via Ynolides:  Cycloproparadicicol. Journal of the American Chemical Society 2003, 125 (32) , 9602-9603. https://doi.org/10.1021/ja036192q
61. Merritt B. Andrus,, Erik L. Meredith,, Bryon L. Simmons,, B. B. V. Soma Sekhar, and, Erik J. Hicken. Total Synthesis of (+)-Geldanamycin and (−)-o-Quinogeldanamycin with Use of Asymmetric Anti- and Syn-Glycolate Aldol Reactions. Organic Letters 2002, 4 (20) , 3549-3552. https://doi.org/10.1021/ol0267432
62. Robert M. Garbaccio,, Shawn J. Stachel,, Daniel K. Baeschlin, and, Samuel J. Danishefsky. Concise Asymmetric Syntheses of Radicicol and Monocillin I. Journal of the American Chemical Society 2001, 123 (44) , 10903-10908. https://doi.org/10.1021/ja011364+
63. Alexander J. Bridges. Chemical Inhibitors of Protein Kinases. Chemical Reviews 2001, 101 (8) , 2541-2572. https://doi.org/10.1021/cr000250y
64. Merritt B. Andrus,, Erik L. Meredith, and, B. B. V. Soma Sekhar. Synthesis of the Left-Hand Portion of Geldanamycin Using an Anti Glycolate Aldol Reaction. Organic Letters 2001, 3 (2) , 259-262. https://doi.org/10.1021/ol0068997
65. Robert M. Garbaccio and, Samuel J. Danishefsky. Efficient Asymmetric Synthesis of Radicicol Dimethyl Ether:  A Novel Application of Ring-Forming Olefin Metathesis. Organic Letters 2000, 2 (20) , 3127-3129. https://doi.org/10.1021/ol0063252
66. Xiao-Fang Cheng, Shi-Tao He, Guo-Qiang Zhong, Jian-Jun Meng, Min Wang, Qi Bi, Rong-Hui Tu. Exosomal HSP90 induced by remote ischemic preconditioning alleviates myocardial ischemia/reperfusion injury by inhibiting complement activation and inflammation. BMC Cardiovascular Disorders 2023, 23 (1) https://doi.org/10.1186/s12872-023-03043-y
67. Cancan Duan, KuoKuo Li, Xiaohua Pan, Zhaolian Wei, Lan Xiao. Hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center. BMC Cancer 2023, 23 (1) https://doi.org/10.1186/s12885-023-10929-9
68. Célia Rouges, Mohammad Asad, Adèle D. Laurent, Pascal Marchand, Patrice Le Pape. Is the C-Terminal Domain an Effective and Selective Target for the Design of Hsp90 Inhibitors against Candida Yeast?. Microorganisms 2023, 11 (12) , 2837. https://doi.org/10.3390/microorganisms11122837
69. Yu-Jung Cheng, Fang-Wei Lee, Yun-Shan Tsai, Yen-Chou Kuan. Tanespimycin and rapamycin exhibit antifungal activity against Colletotrichum gloeosporioides and enhance mango resistance to anthracnose via differentially modulating heat shock response. Postharvest Biology and Technology 2023, 204 , 112474. https://doi.org/10.1016/j.postharvbio.2023.112474
70. Yue Zeng, Jiayu Wang, Sha Huang, Yu Xie, Tongdan Zhu, Leyi Liu, Lin Li. HSP90s are required for hypocotyl elongation during skotomorphogenesis and thermomorphogenesis via the COP1 – ELF3 – PIF4 pathway in Arabidopsis. New Phytologist 2023, 239 (4) , 1253-1265. https://doi.org/10.1111/nph.18776
71. Zineb Belkacemi, Marc Bianciotto, Hervé Minoux, Tony Lelièvre, Gabriel Stoltz, Paraskevi Gkeka. Autoencoders for dimensionality reduction in molecular dynamics: Collective variable dimension, biasing, and transition states. The Journal of Chemical Physics 2023, 159 (2) https://doi.org/10.1063/5.0151053
72. Jaka Dernovšek, Tihomir Tomašič. Following the design path of isoform-selective Hsp90 inhibitors: Small differences, great opportunities. Pharmacology & Therapeutics 2023, 245 , 108396. https://doi.org/10.1016/j.pharmthera.2023.108396
73. Shenping Liu, Bethany L. Kormos, John D. Knafels, Parag V. Sahasrabudhe, Amy Rosado, Ruth F. Sommese, Allan R. Reyes, Jessica Ward, Rachel J. Roth Flach, Xiaochun Wang, Leanne M. Buzon, Matthew R. Reese, Samit K. Bhattacharya, Kiyoyuki Omoto, Kevin J. Filipski. Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors. Journal of Biological Chemistry 2023, 299 (3) , 102959. https://doi.org/10.1016/j.jbc.2023.102959
74. Ayon Chakraborty, Saswati Soumya Mohapatra, Subhashree Barik, Ipsita Roy, Bhavika Gupta, Ashis Biswas. Impact of nanoparticles on amyloid β-induced Alzheimer’s disease, tuberculosis, leprosy and cancer: a systematic review. Bioscience Reports 2023, 43 (2) https://doi.org/10.1042/BSR20220324
75. Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chimeng Tzeng. Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles. International Journal of Molecular Sciences 2023, 24 (3) , 2053. https://doi.org/10.3390/ijms24032053
76. Yuta Murai, Makoto Hashimoto. Heteroaromatic Diazirines Are Essential Building Blocks for Material and Medicinal Chemistry. Molecules 2023, 28 (3) , 1408. https://doi.org/10.3390/molecules28031408
77. Chrisostomos Prodromou, Xavi Aran-Guiu, Jasmeen Oberoi, Laura Perna, J. Paul Chapple, Jacqueline van der Spuy. HSP70-HSP90 Chaperone Networking in Protein-Misfolding Disease. 2023, 389-425. https://doi.org/10.1007/978-3-031-14740-1_13
78. Jing Gao, Chen Zhou, Yan Zhong, Li Shi, Xuanyang Luo, Haixia Su, Minjun Li, Yechun Xu, Naixia Zhang, Hu Zhou. Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines. Biochemical Pharmacology 2023, 207 , 115376. https://doi.org/10.1016/j.bcp.2022.115376
79. Michael Schroda, Catherine deVitry. Molecular chaperones, proteases, and unfolded protein responses. 2023, 647-689. https://doi.org/10.1016/B978-0-12-821430-5.00023-7
80. Rebecca A. Sager, Sarah J. Backe, Len Neckers, Mark R. Woodford, Mehdi Mollapour. Detecting Posttranslational Modifications of Hsp90 Isoforms. 2023, 125-139. https://doi.org/10.1007/978-1-0716-3342-7_11
81. Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar. Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics. 2023, 343-428. https://doi.org/10.1007/978-981-99-2423-3_7
82. Kristine Donahue, Haibo Xie, Miyang Li, Ang Gao, Min Ma, Yidan Wang, Rose Tipton, Nicole Semanik, Tina Primeau, Shunqiang Li, Lingjun Li, Weiping Tang, Wei Xu. Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment. Journal of Biological Chemistry 2022, 298 (12) , 102700. https://doi.org/10.1016/j.jbc.2022.102700
83. Giusy Tassone, Marco Mazzorana, Cecilia Pozzi. Structural Basis of Parasitic HSP90 ATPase Inhibition by Small Molecules. Pharmaceuticals 2022, 15 (11) , 1341. https://doi.org/10.3390/ph15111341
84. Mina Ardestani, Zahra Khorsandi, Fariba Keshavarzipour, Siavash Iravani, Hojjat Sadeghi-Aliabadi, Rajender S. Varma. Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications. Pharmaceutics 2022, 14 (10) , 2220. https://doi.org/10.3390/pharmaceutics14102220
85. Karna Ramachandraiah, Ramesh Thylur Puttalingaiah. The role of mixed lineage kinase 3 (MLK3) in cancers. Pharmacology & Therapeutics 2022, 238 , 108269. https://doi.org/10.1016/j.pharmthera.2022.108269
86. Jian Zhang, Houde Li, Yu Liu, Kejia Zhao, Shiyou Wei, Eric T. Sugarman, Lunxu Liu, Gao Zhang. Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance. Cells 2022, 11 (18) , 2778. https://doi.org/10.3390/cells11182778
87. Weitao Zhang, Hanyue Xue, Chen Zhou, Zuguo Zheng, Mingming Xing, Hang Chu, Ping Li, Naixia Zhang, Yongjun Dang, Xiaojun Xu. 7-aminocephalosporanic acid, a novel HSP90β inhibitor, attenuates HFD-induced hepatic steatosis. Biochemical and Biophysical Research Communications 2022, 622 , 184-191. https://doi.org/10.1016/j.bbrc.2022.07.033
88. Yiming Xu, Panke Zeng, Haodong Wang, Keyan Han, Gan Qiu, Yongquan Wei, Rui Chen, Lisheng Wang, Xu Liu. Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect. Drug Development Research 2022, 83 (6) , 1434-1454. https://doi.org/10.1002/ddr.21974
89. Gang-Long Jiang, Lian-Hua Song, Yong-Fu Qiu, Yu Liu. 3D-QSAR and Docking Studies on Pyrimidine Derivatives of Second-Generation ALK Inhibitors. Pharmaceutical Fronts 2022, 31 https://doi.org/10.1055/s-0042-1750044
90. Milán Somogyvári, Saba Khatatneh, Csaba Sőti. Hsp90: From Cellular to Organismal Proteostasis. Cells 2022, 11 (16) , 2479. https://doi.org/10.3390/cells11162479
91. Giusy Tassone, Marco Mazzorana, Stefano Mangani, Elena Petricci, Elena Cini, Giuseppe Giannini, Cecilia Pozzi, Samuele Maramai. Structural Characterization of Human Heat Shock Protein 90 N-Terminal Domain and Its Variants K112R and K112A in Complex with a Potent 1,2,3-Triazole-Based Inhibitor. International Journal of Molecular Sciences 2022, 23 (16) , 9458. https://doi.org/10.3390/ijms23169458
92. Goran Poje, Lais Pessanha de Carvalho, Jana Held, Diana Moita, Miguel Prudêncio, Ivana Perković, Tana Tandarić, Robert Vianello, Zrinka Rajić. Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents. European Journal of Medicinal Chemistry 2022, 238 , 114408. https://doi.org/10.1016/j.ejmech.2022.114408
93. Hsien-Tzu Wang, Yu-Jung Cheng, Jhih-Ting Hsiao, Fuu Sheu, Yen-Chou Kuan. 17-(Allylamino)-17-demethoxygeldanamycin treatment induces the accumulation of heat shock proteins and alleviates senescence in broccoli. Postharvest Biology and Technology 2022, 186 , 111818. https://doi.org/10.1016/j.postharvbio.2021.111818
94. Roopa Gaonkar, Jitender Singh, Arushi Chauhan, Pramod K. Avti, Gurumurthy Hegde. Geraniol and Citral as potential therapeutic agents targeting the HSP90 activity: An in silico and experimental approach. Phytochemistry 2022, 195 , 113058. https://doi.org/10.1016/j.phytochem.2021.113058
95. Shilpa Kuttikrishnan, Kirti S. Prabhu, Ahmed H. Al Sharie, Yazan O. Al Zu'bi, Feras Q. Alali, Nicholas H. Oberlies, Aamir Ahmad, Tamam El-Elimat, Shahab Uddin. Natural resorcylic acid lactones: A chemical biology approach for anticancer activity. Drug Discovery Today 2022, 27 (2) , 547-557. https://doi.org/10.1016/j.drudis.2021.10.001
96. Ayon Chakraborty, Rajesh Ghosh, Ashis Biswas. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function. The FEBS Journal 2022, 289 (3) , 832-853. https://doi.org/10.1111/febs.16212
97. Magda H. Abdellattif, Ahmed Elkamhawy, Hossam Nada. Synthesis, Biological Evaluation, and In Silico Studies of New Heterocycles Incorporating 4,5,6,7-Tetrabromophthalimide Moiety as Potential Antibacterial and Anticancer Agents. HETEROCYCLES 2022, 104 (5) , 855. https://doi.org/10.3987/COM-21-14535
98. Mark J. de Keijzer, Daniel J. de Klerk, Lianne R. de Haan, Robert T. van Kooten, Leonardo P. Franchi, Lionel M. Dias, Tony G. Kleijn, Diederick J. van Doorn, Michal Heger, . Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy. 2022, 285-403. https://doi.org/10.1007/978-1-0716-2099-1_19
99. Manzar Alam, Ahmad Abu Turab Naqvi, Md. Imtaiyaz Hassan. Emerging Role of Structural and Systems Biology in Anticancer Therapeutics. 2022, 97-114. https://doi.org/10.1007/978-981-19-1953-4_5
100. Karna Ramachandraiah, Ramesh Thylur Puttalingaiah. The Role of Mixed Lineage Kinase 3 (MLK3) in Cancers. SSRN Electronic Journal 2022, 41 https://doi.org/10.2139/ssrn.4164405